Evidence map›Paper›PMID 22105070›Full record

ArticleThe Journal of biological chemistry2012

Histidine 66 in Escherichia coli elongation factor tu selectively stabilizes aminoacyl-tRNAs.

Stephen J Chapman, Jared M Schrader, Olke C Uhlenbeck

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stephen J ChapmanDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, USA.
Jared M Schrader
Olke C Uhlenbeck
Northwestern University · US

Funding

NUCLEOTIDE SUBSTITUTION IN TRNAR01GM037552 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI UHLENBECK, OLKE C · 1985 to 2013
$3.9M
NIGMS NIH HHS GM037552NIGMS NIH HHS R01 GM037552
6 · The paper itself

Abstract

The universally conserved His-66 of elongation factor Tu (EF-Tu) stacks on the side chain of the esterified Phe of Phe-tRNA(Phe). The affinities of eight aminoacyl-tRNAs were differentially destabilized by the introduction of the H66A mutation into Escherichia coli EF-Tu, whereas Ala-tRNA(Ala) and Gly-tRNA(Gly) were unaffected. The H66F and H66W proteins each show a different pattern of binding of 10 different aminoacyl-tRNAs, clearly showing that this position is critical in establishing the specificity of EF-Tu for different esterified amino acids. However, the H66A mutation does not greatly affect the ability of the ternary complex to bind ribosomes, hydrolyze GTP, or form dipeptide, suggesting that this residue does not directly participate in ribosomal decoding. Selective mutation of His-66 may improve the ability of certain unnatural amino acids to be incorporated by the ribosome.

Indexed as

Amino Acid SubstitutionEscherichia coliEscherichia coli ProteinsGuanosine TriphosphateHistidineHydrolysisMutation, MissensePeptide Elongation Factor TuRibosomesRNA, Transfer, Amino AcylEscherichia coli ProteinsGuanosine TriphosphateHistidinePeptide Elongation Factor TuRNA, Transfer, Amino Acyl

Identifiers

PMID22105070
PMCPMC3256880
OpenAlexW2020651381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.